Institutional Conflict of Interest Management and Monitoring Plan: Spectrum Pharmaceuticals, Inc.Exclusive Patent and Technology License Agreement • April 18th, 2019
Contract Type FiledApril 18th, 2019The University of Texas MD Anderson (MD Anderson) and Spectrum Pharmaceuticals, Inc. (Spectrum) are parties to an Exclusive Patent and Technology License Agreement (Agreement) pursuant to which MD Anderson and (Spectrum) will collaborate on the conduct of at least two Phase II clinical trials and possibly other trials involving MD Anderson’s Licensed Technology.